Intracellular clusterin negatively regulates ovarian chemoresistance: Compromised expression sensitizes ovarian cancer cells to paclitaxel

Tumor Biology

Volumn 32, Issue 5, 2011, Pages 1031-1047

  Hassan, Mohamed Kamel ^a,b   Watari, Hidemichi ^a   Christenson, Lane ^c   Bettuzzi, Saverio ^d,e   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PORT SAID UNIVERSITY   (Egypt)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PARMA   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Chemoresistance; Intracellular clusterin; Ovarian cancer; Paclitaxel

Indexed keywords

CLUSTERIN; KU ANTIGEN; PACLITAXEL;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIZATION; FEMALE; HUMAN; HUMAN CELL; IC 50; INTRACELLULAR SPACE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 80052339188     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0207-0     Document Type: Article

References (62)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel R, et al. Global cancer facts and figures. Atlanta: American Cancer Society; 2007.
2. FY Ahmed E Wiltshaw P Ahern B Nicol J Shepherd P Blake, et al. 1996 Natural history and prognosis of untreated stage I epithelial ovarian carcinoma J Clin Oncol 14 2968 2975 8918494 1:STN:280:DyaK2s%2Fns1WktQ%3D%3D (Pubitemid 26371455)
3. MS Piver J Malfetano TR Baker RE Hempling 1992 Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy Gynecol Oncol 46 357 360 1526515 10.1016/0090-8258(92)90232-8 1:STN:280:DyaK38vgs1SktQ%3D%3D
4. JD Wright M Shah L Mathew WM Burke J Culhane N Goldman, et al. 2009 Fertility preservation in young women with epithelial ovarian cancer Cancer 115 4118 4126 19670446 10.1002/cncr.24461
5. M Miller I Ojima 2001 Chemistry and chemical biology of taxan anticancer agents Chem Rec 1 195 211 11895119 10.1002/tcr.1008 1:CAS:528: DC%2BD3MXmt1SqtL4%3D (Pubitemid 33771705)
6. D Petrylak 2003 Docetaxel for the treatment of hormone-refractory prostate cancer Rev Urol 5 14 21
7. M Fung-Kee-Fung T Oliver L Elit A Oza HW Hirte P Bryson 2007 Optimal chemotherapy treatment for women with recurrent ovarian cancer Curr Oncol 14 195 208 17938703 10.3747/co.2007.148 1:STN:280:DC%2BD2snhsVGitw%3D%3D
8. WP McGuire M Markman 2003 Primary ovarian cancer chemotherapy: current standards of care British J Cancer 89 3 8 10.1038/sj.bjc.6601494
9. RF Ozols RC Young 1984 Chemotherapy of ovarian cancer Semin Oncol 11 251 263 6435250 1:STN:280:DyaL2M%2Fhs1KrsA%3D%3D (Pubitemid 14013132)
10. WP McGuire WJ Hoskins MF Brady PR Kucera EE Partridge KY Look, et al. 1996 Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer Nat Engl J Med 334 1 6 10.1056/NEJM199601043340101 1:CAS:528:DyaK28XhtFKiur4%3D (Pubitemid 26012496)
11. D Selimovic M Hassan Y Haikel UR Hengge 2008 Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2 Cell Signaling 2 311 322 10.1016/j.cellsig.2007.10.015
12. A Richardson S Kaye 2005 Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance Drug Resist Updat 5 311 321 10.1016/j.drup.2005.09.001 (Pubitemid 41677714)
13. S Bettuzzi RA Hiipakka P Gilna S Liao 1989 Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis Biochem J 257 293 296 2920020 1:CAS:528:DyaL1MXntVeqtA%3D%3D (Pubitemid 19034548)
14. B Aronow SD Lund TL Brown JK Harmony DP Witte 1993 Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection Proc Natl Acad Sci 90 725 729 8421712 10.1073/pnas.90.2.725 1:CAS:528: DyaK3sXnslKrsA%3D%3D (Pubitemid 23028938)
15. M Fratelli G Galli M Minto GM Pasinetti 1996 Role of clusterin in cell adhesion during early phases of programmed cell death in P19 embryonic carcinoma cells Biochim Biophys Acta 1311 71 761 8630332 10.1016/0167-4889(95)00192-1 (Pubitemid 26143647)
16. S Bettuzzi F Scorcioni S Astancolle P Davalli M Scaltriti A Corti 2002 Clusterin (SGP-2) transient over-expression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression Oncogene 21 4328 4334 12082621 10.1038/sj.onc.1205594 1:CAS:528:DC%2BD38XkslKmtLY%3D (Pubitemid 34753840)
17. IP Trougakos ES Gonos 2002 Clusterin/apolipoprotein J in human aging and cancer Int J Biochem Cell Biol 11 1430 1448 10.1016/S1357-2725(02)00041-9 (Pubitemid 35245400)
18. J O'Sullivan L Whyte J Drake M Tenniswood 2003 Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis Cell Death Differ 10 914 927 12867999 10.1038/sj.cdd.4401254 (Pubitemid 36939702)
19. AE Caccamo MA Scaltriti A Caporali D D'Arca F Scorcioni G Candiano, et al. 2003 Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells Ann NY Acad Sci 1010 514 519 15033782 10.1196/annals.1299.095 1:CAS:528: DC%2BD2cXisFertro%3D (Pubitemid 38265036)
20. IP Trougakos A So B Jansen ME Gleave ES Gonos 2004 Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress Cancer Res 5 1834 1842 10.1158/0008-5472.CAN-03-2664 (Pubitemid 38428709)
21. D Xie SH Lau JS Sham QL Wu Y Fang LZ Liang, et al. 2005 Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma Cancer 2 277 283 10.1002/cncr.20765 (Pubitemid 40129286)
22. M Scaltriti M Brausi A Amorosi G Castagnetti S Astancolle AA Corti, et al. 2004 Clusterin (SGP-2, ApoJ) expression is down-regulated in low- and high-grade human prostate cancer Int J Cancer 108 23 30 14618611 10.1002/ijc.11496 1:CAS:528:DC%2BD3sXps1entL4%3D (Pubitemid 37444439)
23. S Pucci E Bonanno F Pichiorri C Angeloni LG Spagnoli 2004 Modulation of different clusterin isoforms in human colon tumorigenesis Oncogene 13 2298 2304 10.1038/sj.onc.1207404 (Pubitemid 38496784)
24. M Gleave H Miyake 2005 Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer World J Urol 1 38 46 10.1007/s00345-004-0474-0 (Pubitemid 40430679)
25. B Shannan M Seifert K Leskov J Willis D Boothman W Tilgen, et al. 2006 Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death Differ 1 12 19 10.1038/sj.cdd.4401779
26. MW Collard MD Griswold 1987 Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells Biochemistry 26 3297 3303 3651384 10.1021/bi00386a008 1:CAS:528:DyaL2sXktFyksLg%3D
27. AM Clark MD Griswold 1997 Expression of clusterin/sulfated glycoprotein-2 under conditions of heat stress in rat Sertoli cells and a mouse Sertoli cell line J Androl 18 257 263 9203053 1:CAS:528:DyaK2sXks1Srsbs%3D (Pubitemid 27265959)
28. L Kirszbaum SE Bozas ID Walker 1992 SP-40, 40, a protein involved in the control of the complement pathway, possesses a unique array of disulfide bridges FEBS Lett 297 70 76 1551440 10.1016/0014-5793(92)80330-J 1:CAS:528: DyaK38XhslWqsb8%3D
29. KS Leskov DY Klokov J Li TJ Kinsella DA Boothman 2003 Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 278 11590 11600 12551933 10.1074/jbc.M209233200 1:CAS:528:DC%2BD3sXit1Kgtb0%3D (Pubitemid 36792721)
30. AE Caccamo M Scaltriti A Caporali D D'Arca F Scorcioni S Astancolle, et al. 2004 Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin Biochemical J 382 157 168 10.1042/BJ20040158 1:CAS:528:DC%2BD2cXmsVChtr8%3D (Pubitemid 39141577)
31. CR Yang S Yeh K Leskov E Odegaard HL Hsu C Chang, et al. 1999 Isolation of Ku70 binding proteins Nucleic Acids Res 10 2165 2174 10.1093/nar/27.10.2165 (Pubitemid 29219245)
32. MK Hassan 2008 An association between clusterin over-expression and taxol-resistance in ovarian cancer Hokkaido Igaku Zasshi 83 335 346 18946958 1:CAS:528:DC%2BD1cXhtlGqsr%2FJ
33. K Zhu IM Fukasawa M Fujinoki M Furno F Inaba T Yamazaki, et al. 2005 Profiling of proteins associated with cisplatin resistance in ovarian cancer cells Int J Gynecol Cancer 15 747 754 16174219 10.1111/j.1525-1438.2005.00247.x 1:STN:280:DC%2BD2Mrgt1KltA%3D%3D (Pubitemid 41783076)
34. KB Reddy G Jin MC Karode JAK Harmony PH Howe 1996 Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells Biochemistry 35 6157 6163 8634259 10.1021/bi952981b 1:CAS:528:DyaK28XisV2jsLs%3D (Pubitemid 26147589)
35. MA Al-Mohanna FM Al-Khodairy Z Krezolek PA Bertilsson KA Al-Houssein A Aboussekhra 2001 p53 is dispensable for UV-induced cell cycle arrest at late G(1) in mammalian cells Carcinogenesis 22 573 578 11285191 10.1093/carcin/22.4. 573 1:CAS:528:DC%2BD3MXivVCgtLo%3D (Pubitemid 32288657)
36. JA Sensibar DM Sutkowski A Raffo 1995 Prevention of cell death induced by tumornecrosis factor alpha in LNCaP cells by over-expression of sulfated glycoprotein-2 (clusterin) Cancer Res 55 2431 2437 7757997 1:CAS:528: DyaK2MXlvFeqs7c%3D
37. I Viard P Wehrli L Jornot 1999 Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress J Invest Dermatol 112 290 296 10084304 10.1046/j.1523-1747.1999.00531.x 1:CAS:528:DyaK1MXhs12nu7c%3D (Pubitemid 29125103)
38. H Miyake KN Chi ME Gleave 2000 Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo Clin Cancer Res 6 1655 1663 10815883 1:CAS:528: DC%2BD3cXktVWisrw%3D (Pubitemid 30305057)
39. H Miyake C Nelson PS Rennie ME Gleave 2000 Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer Cancer Res 60 170 176 10646870 1:CAS:528:DC%2BD3cXnt1antw%3D%3D (Pubitemid 30058748)
40. AJ Wu II Park L Zhaung C Lee 2002 Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells Prostate 53 277 285 12430139 10.1002/pros.10158 1:CAS:528:DC%2BD38Xps1ymt7s%3D (Pubitemid 35398498)
41. M Redondo E Villar J Torres-Munoz T Tellez M Morell CK Petito 2000 Over-expression of clusterin in human breast carcinoma Am J Pathol 157 393 399 10934144 10.1016/S0002-9440(10)64552-X 1:CAS:528:DC%2BD3cXlvFyru7s%3D (Pubitemid 30626904)
42. JM Albert A Gonzalez PP Massion H Chen SJ Olson Y Shyr, et al. 2007 Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer Cancer Epidemiol Biomarkers Prev 16 1845 1851 17855704 10.1158/1055-9965.EPI-07-0146 1:CAS:528:DC%2BD2sXhtVaktr7O (Pubitemid 47450516)
43. H Miyake M Gleave S Kamidono I Hara 2002 Over-expression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence Urology 59 150 154 11796313 10.1016/S0090-4295(01)01484-4 (Pubitemid 34059338)
44. M Scaltriti A Santamaria R Paciucci S Bettuzzi 2004 Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells Cancer Res 64 6174 6182 15342402 10.1158/0008-5472.CAN-04-0920 1:CAS:528:DC%2BD2cXntFClsbg%3D (Pubitemid 39129419)
45. AE Caccamo M Scaltriti A Caporali D D'Arca A Corti D Corvetta, et al. 2005 Ca2p depletion caused nuclear translocation of a 45 kDa death-isoform of clusterin and anoikis induction in prostate cells Cell Death Differ 12 101 104 15499376 10.1038/sj.cdd.4401491 1:CAS:528:DC%2BD2cXhtVGmtbzO (Pubitemid 40090035)
46. B Pajak A Orzechowski 2006 Clusterin. the missing link in the calcium-dependent resistance of cancer cells to apoptogenic stimuli Postepy Hig Med Dosw 60 45 51
47. L Wei T Xue J Wang B Chen Y Lei Y Huang, et al. 2009 Roles of clusterin in progression, chemo-resistance and metastasis of human ovarian cancer Int J Can 15 791 806 10.1002/ijc.24316
48. MR Moretti MM Marelli A Cariboni 2007 Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis Cancer Res 67 10325 10333 17974975 10.1158/0008-5472.CAN-07-0516 1:CAS:528:DC%2BD2sXht1erurzK (Pubitemid 350070807)
49. M Al-Mohanna P Manogaran Z Al-Mukhalafi K Al-Hussein A Aboussekhra 2004 The tumor suppressor p16INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin Oncogene 23 201 212 14712225 10.1038/sj.onc.1206927 1:CAS:528:DC%2BD2cXovVKhsA%3D%3D (Pubitemid 38142254)
50. Y Chow A Choudhury 2005 DNA repair protein: endo-exonuclease as a new frontier in cancer therapy Future Oncol 2 265 271 10.1517/14796694.1.2.265
51. CM Sorenso A Eastman 1988 Influence of cis-diamminedichloroplatinum (II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells Cancer Res 23 6703 6707 (Pubitemid 19012192)
52. B Shannan AM Seifert AD Boothman W Tilgen J Reichrath 2006 Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control J Mol Hist 37 183 188 10.1007/s10735-006-9052-7 1:CAS:528:DC%2BD28Xht1elsLnO (Pubitemid 44795623)
53. M Kempt G Sedgwick A Jeggo 1984 X-ray sensitive mutants of CHO cells defective in double strand break rejoining Mutat Res 13 189 196
54. A Jeggo K Caldecott S Pidsley R Banks 1989 Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors Cancer Res 49 7057 7063 2479475 1:STN:280:DyaK3c%2FlvVGksw%3D%3D (Pubitemid 20016593)
55. K Caldecotti G Banks P Jeggo 1990 DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II Cancer Res 18 5778 5783 (Pubitemid 20331376)
56. RC Getts TD Stamato 1994 Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant J Biol Chem 269 15981 15984 8206892 1:CAS:528:DyaK2cXkt1ymsLo%3D (Pubitemid 24209279)
57. GE Taccioli TM Gottlieb T Blunt A Priestley J Demengeot R Mizuta, et al. 1994 Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination Science 5177 1442 1445 10.1126/science.8073286 (Pubitemid 24306796)
58. AM Gullo G Feng G Teoh 2006 The biology of Ku and its potential oncogenic role in cancer Biochimica et Biophysica 1765 223 234 1:CAS:528: DC%2BD28XktVyjtbs%3D
59. S Bettuzzi F Rizzi 2009 Nuclear CLU (nCLU) and the fate of the cell Adv Cancer Res 104 59 88 19878773 10.1016/S0065-230X(09)04005-6 1:CAS:528: DC%2BC3cXmt1yjtg%3D%3D
60. S Pucci S Bettuzzi 2009 The shifting balance between CLU forms during tumor progression Adv Cancer Res 104 25 32 19878771 10.1016/S0065-230X(09)04003- 2 1:CAS:528:DC%2BC3cXmt1yjsA%3D%3D
61. F Rizzi M Coletta S Bettuzzi 2009 Clusterin (CLU): from one gene and two transcripts to many proteins Adv Cancer Res 104 9 23 19878770 10.1016/S0065-230X(09)04002-0 1:CAS:528:DC%2BC3cXmt1yjsw%3D%3D
62. S Bettuzi S Astancolle G Guidetti M Moretti A Tiozzo A Corti 1999 Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts FEBS Lett 448 297 300 10.1016/S0014-5793(99)00375-0 (Pubitemid 29168507)